https://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223378.%255BKeynote%2BSession%255D%2BCurrent%2BStatus%2Band%2BPromise%2Bof%2BmRNA%2BBiotherapeutics.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223395.%255BTechnical%2BSession%2B04%255D%2BGLP-1%253A%2BExpansion%2Bfrom%2BDiabetes%2Bto%2BObesity%252C%2BHeart%2BDisease%2Band%2BParkinson%2527s.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223382.%255BTechnical%2BSession%2B01%255D%2BPublic%2BFund%2BManagement%2BStrategies%2Bby%2BDomestic%2BVCs.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223387.%255BTechnical%2BSession%2B02%255D%2BInnovation%2Bin%2BmRNA%2BBiotherapeutics%2BManufacturing%2B%2540MIT.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223653.%255BInsight%2BSession%2B03%255D%2BLONZA.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223396.%255BTechnical%2BSession%2B05%255D%2BEmerging%2BIssues%2Band%2BHot%2BTopics%2Bfrom%2BFDA%2BCompliance%2Band%2BRegulatory%2BPerspective.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223651.%255BInsight%2BSession%2B01%255D%2BMERCK.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223694.%255BInsight%2BSession%2B04%255D%2BEnvirotainer.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223652.%255BInsight%2BSession%2B02%255D%2BSartorius.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223397.%255BTechnical%2BSession%2B06%255D%2BRegulatory%2BAffairs%2Bfor%2BClinical%2BTrials%2Bin%2BEurope.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223392.%255BTechnical%2BSession%2B03%255D%2BIntelligent%2BStrategies%2Bfor%2BDrug%2B%2526%2BMedical%2BDevice%2BDevelopment%2Bfrom%2BClinicians%25E2%2580%2599%2BPerspective.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223687.%255BInsight%2BSession%2B08%255D%2BAcrobiosystems.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223650.%255BTechnical%2BSession%2B07%255D%2BBIO%2BUSA%2B2024%2BDEBRIEFING.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223684.%255BInsight%2BSession%2B05%255D%2BIQVIA.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223688.%255BInsight%2BSession%2B09%255D%2BSAMSUNG%2BBIOLOGICS.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223398.%255BTechnical%2BSession%2B08%255D%2BInnovation%2Band%2BInvestment%2BOpportunities%2Bin%2BMASH.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223404.%255BTechnical%2BSession%2B12%255D%2BTrailblazing%2Bdeals%2Bin%2Bthe%2Bhealthcare%2Bindustry.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223399.%255BTechnical%2BSession%2B09%255D%2B2030%2BGlobal%2BBD%2BPartnering%2BTREND%2BREPORT.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223412.%255BTechnical%2BSession%2B13%255D%2BGlobal%2BPre-commercialization%2BStrategy%2Bfor%2BKorea%2BBiotechs.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223685.%255BInsight%2BSession%2B06%255D%2BSolventum.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223689.%255BInsight%2BSession%2B10%255D%2BThermo%2BFisher%2BScientific.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223400.%255BTechnical%2BSession%2B10%255D%2BExplore%2Binto%2BGlobal%2BIPO%2BOpportunities.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223686.%255BInsight%2BSession%2B07%255D%2BSAMSUNG%2BBIOEPIS.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223690.%255BInsight%2BSession%2B11%255D%2BBD.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223402.%255BTechnical%2BSession%2B11%255D%2BUpscaling%2Bthe%2BKorean%2BBIO%2BMPE%2B%2528BIO%2BMaterials%252C%2BParts%2Band%2BEquipment%2529%2BMarket.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223414.%255BTechnical%2BSession%2B14%255D%2BEntry%2BStrategies%2Bto%2Bthe%2BLeading%2BBio%2BMarkets.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223415.%255BTechnical%2BSession%2B15%255D%2BStart%2Bmanaging%2Byour%2Bhealth%2Bwith%2Bgene%2Banalysis.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223419.%255BTechnical%2BSession%2B19%255D%2BCultivated%2BMeat%253A%2BPromise%2Bof%2BFuture%2BFood%2BSecurity.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223416.%255BTechnical%2BSession%2B16%255D%2BNew%2BModels%2Bfor%2BSuccessful%2BBio-healthcare%2BStartups.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223417.%255BTechnical%2BSession%2B17%255D%2BWhat%2BMakes%2BKorean%2BBio-health%2BAttractive%2Bfor%2BForeign%2BInvestors%253F.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223420.%255BTechnical%2BSession%2B20%255D%2BOutlook%2Bon%2Bthe%2BFuture%2Bof%2BDigital%2BHealthcare%2Bin%2Bthe%2BEra%2Bof%2BGenerative%2BAI.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223691.%255BInsight%2BSession%2B12%255D%2BIDBS.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223692.%255BInsight%2BSession%2B13%255D%2B%2BWest%2BPharmaceutical.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223418.%255BTechnical%2BSession%2B18%255D%2BNewest%2BCGT%2Btechnologies%2Bfor%2Bwinning%2Bthe%2Bwar%2Bon%2Bcancer.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/conference/archives/archives_BIX2024/session-details.3948.223421.%255BTechnical%2BSession%2B21%255D%2BU.S%2Bthe%2BLand%2Bof%2BOpportunity%2Bfor%2BRemote%2BHealthcare%2BBusiness.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.251332.%255BKeynote%2BSession%255D%2BThe%2BRole%2Bof%2BCellular%2Band%2BRegenerative%2BMedicine%2Bin%2BLongevity%2Band%2BHuman%2BPerformance.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.251337.%255BTechnical%2BSession%2B01%255D%2BReady%2Bto%2Bjump%2Boff%2Bthe%2Bpatent%2Bcliff%253F%2BA%2Bglobal%2Bperspective%2Bon%2Bbiopharma%25E2%2580%2599s%2Bhunt%2Bfor%2Bthe%2Bnext%2Bblockbusters.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.251338.%255BTechnical%2BSession%2B02%255D%2BHow%2BFDA%25E2%2580%2599s%2BNew%2BRules%2BAre%2BReshaping%2Bthe%2BFuture%2Bof%2BGlobal%2BBiotech.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.253654.%255BLuncheon%2BSession%255D%2BLuncheon%2BSession%2Bwith%2BLonza.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.251339.%255BTechnical%2BSession%2B03%255D%2BAnti-Aging%253A%2BThe%2BNext%2BBio%2BFrontier%253F%2B%25E2%2580%2593%2BChallenges%2Band%2BStrategies%2BBeyond%2BScience%252C%2BRegulation%252C%2Band%2Bthe%2BMarket.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.251340.%255BTechnical%2BSession%2B04%255D%2BBiotech%25E2%2580%2599s%2BESG%2BDisclosure%2BGap%253A%2BHow%2BPrepared%2BAre%2BWe%253F.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.253042.%255BInsight%2BSession%2B01%255D%2BDigital%2BPlatform%2Bfor%2BADC%2Band%2BAAV%2BDrug%2BDevelopment.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.253043.%255BInsight%2BSession%2B02%255D%2BAdaptive%2BCell%2BLine%2BDevelopment%253A%2BToolbox%2BStrategies%2Bfor%2BComplex%2BMolecules.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.253906.%255BInsight%2BSession%2B03%255D%2BReshaping%2BR%2526D%253A%2BBiopharma%25E2%2580%2599s%2BGlobal%2BReset.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.253044.%255BInsight%2BSession%2B04%255D%2BThe%2BBora%2BWay%253A%2BTechnology%2Band%2BVirtual%2BReality%2BShaping%2Bthe%2BFuture%2Bof%2BFill%252FFinish%2BExcellence.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.251341.%255BTechnical%2BSession%2B05%255D%2BNew-Co.%2Bjust%2Ba%2Bspin-off%2Bor%2Ban%2BInnovative%2BBusiness%2BStructure%253F.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.251342.%255BTechnical%2BSession%2B06%255D%2BBuilding%2BCross-Border%2BCommercialization%2BPathways.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.251336.%255BFeatured%2BSession%255D%2BThe%2BTransformation%2Bof%2BHealth%2Bby%2BTechnology.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.251343.%255BTechnical%2BSession%2B07%255D%2BNext-Generation%2BWhiteBio%2BBusiness%2BModel%253A%2BCarbon%2BCirculation%2BPlatform.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.251344.%255BTechnical%2BSession%2B08%255D%2BUS%2BIndustry%2BInsights%2Bfor%2BKorea%25E2%2580%2599s%2BGlobal%2BLeap.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.253045.%255BInsight%2BSession%2B05%255D%2BSustainable%2BManufacturing%2Bof%2BSingle-use%2BBioreactor%2Bbased%2Bprocess.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.253046.%255BInsight%2BSession%2B06%255D%2BFlexible%2Bpackaging%2Bsolutions%2Bfor%2Bglobal%2Bclinical%2Bsupply%2Bagility.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.253656.%255BPress%2BBriefing%255D%2BPress%2BBriefing%2Bby%2BCytiva.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.251345.%255BTechnical%2BSession%2B09%255D%2BAccelerating%2BADC%2BGlobalization%253A%2BTrends%252C%2BChallenges%252C%2Band%2BStrategic%2BCollaborations.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.251346.%255BTechnical%2BSession%2B10%255D%2BInnovation%2BDriven%2BDrug%2BDiscovery%2Bin%2BReal%2BFields.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.253655.%255BLuncheon%2BSession02%255D%2BLuncheon%2BSession%2Bwith%2BSamsung%2BBiologics.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.251347.%255BTechnical%2BSession%2B11%255D%2BRadiopharma%2BRevolution%253A%2BUnmet%2BNeeds%252C%2BInnovation%252C%2Band%2BGlobal%2BAccess.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.251349.%255BTechnical%2BSession%2B12%255D%2BGlobal%2BPharma%2BCold%2BChain%2BInnovation%253A%2BGDP%2BCompliance%2Band%2BSustainable%2BLogistics.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.253047.%255BInsight%2BSession%2B07%255D%2BBridging%2BChemical%2BCompatibility%2Band%2BExtractables%253A%2BA%2BHolistic%2BApproach%2Bfor%2BSafe%2Band%2BEffective%2BADC%2BManufacturing.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.253048.%255BInsight%2BSession%2B08%255D%2BAddressing%2BChallenges%2Bin%2BAntibody-Drug%2BConjugate%2BDevelopment.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.253049.%255BInsight%2BSession%2B09%255D%2BWinning%2Bin%2Ba%2BTransforming%2BMarket%253A%2BDriving%2BInnovation%2Bwith%2BBD%25E2%2580%2599s%2BNext-Gen%2BConcepts.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.253116.%255BInsight%2BSession%2B10%255D%2BEnvirotainer.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.251351.%255BTechnical%2BSession%2B13%255D%2BKOSDAQ%2BListing%2BStrategies%2Bfor%2BBio%2BCompanies%253A%2BDeep%2BDive%2Binto%2BSpecial%2BTechnology%2BListing%2BTrack.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.251352.%255BTechnical%2BSession%2B14%255D%2BConnecting%2Bthe%2BKorea-Japan%2BBio%2BEcosystem%253A%2BStrategies%2Bfor%2BOpen%2BInnovation.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.253652.%255BReception%255D%2BIR%2BPitching%2B%2526%2BNetworking%2BEvent%2Bwith%2BGCCL.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.251353.%255BTechnical%2BSession%2B15%255D%2BChina%2BBiotech%25E2%2580%2599s%2B%25E2%2580%2598Deepseek%25E2%2580%2599%2BMoment%2BIs%2BComing.%2BAre%2BYou%2BReady%253F.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.251354.%255BTechnical%2BSession%2B16%255D%2BNavigating%2BFuture%2BGrowth%2Bthrough%2BBiotech%2BM%2526A.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.253117.%255BInsight%2BSession%2B11%255D%2BWest%2BPharmaceutical.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.251355.%255BTechnical%2BSession%2B17%255D%2BEmerging%2BTrends%2Bin%2BBio%2BM%25C2%25B7P%25C2%25B7E%2B%2528Materials%252C%2BParts%2Band%2BEquipments%2529%252C%2BCold%2BChain%252C%2Band%2BAI%2BApplications.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.251356.%255BTechnical%2BSession%2B18%255D%2BK-Digital%2BHealthcare%253A%2BBeyond%2BBorders.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.251357.%255BTechnical%2BSession%2B19%255D%2BLicensing-Out%2BStrategies%2Bfor%2BK-Bio%253A%2BUnlocking%2BGlobal%2BOpportunities.htmlhttps://www.bioplusinterphex.co.kr/en-us/conference02/Session_directory/SessionsDetail.4677.253653.%255BReception%255D%2BYoung%2BProfessional%2BReception%252C%2Bsponsored%2Bby%2BJLABS.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/Open_Innovation/outline/SessionsDetail.4691.253050.The%2BLeap-In%2BTransposase%2BPlatform%253A%2BDesigned%2BCell%2BLine%2BDevelopment%2Bfor%2BAntibodies%2Band%2BBispecifics.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/Open_Innovation/outline/SessionsDetail.4691.253100.The%2B3rd%2BChina%25E2%2580%2593Korea%2BLife%2Band%2BHealth%2BIndustry%2BCooperation%2BExchange%2BConference.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/Open_Innovation/outline/SessionsDetail.4691.253051.Smart%2Bmanufacturing%2Bwith%2Bintelligent%2Bsensors%2BShifting%2Bfrom%2BOff-line%2Bto%2BIn-line%2BQuality%2BControl%2Bin%2BSingle-Use%2BBiomanufacturing%253A%2BTrends%252C.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/Open_Innovation/outline/SessionsDetail.4691.253052.End-to-End%2BVisibility%2Bfor%2BIntegrated%2BPharma%2BSupply%2BChains.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/Open_Innovation/outline/SessionsDetail.4691.253053.Digital%2BHealth%2BAdvancing%2BThrough%2BAX%2BInnovation.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/Open_Innovation/outline/SessionsDetail.4691.253054.2025%2BAdvance%2BBiotech%2BGrant%2BProgram%2BKorea.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/Open_Innovation/outline/SessionsDetail.4691.253055.Mitigating%2BRisk%2Bin%2BBiologics%2BDevelopment%2BFrom%2BIND%2Bto%2BBLA.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/Open_Innovation/outline/SessionsDetail.4691.253056.Transition%2Bto%2Bthe%2BSmart%2BLab%253A%2BABLE%2BLabs%2527%2BSolutions%2Bfor%2BLaboratory%2BAutomation.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/Open_Innovation/outline/SessionsDetail.4691.253058.BASF%2BGMP%2BSolution%2Bfor%2BCell%2BCulture%2Band%2BFormulation%2BStabilisation%253A%2BKolliphor%25C2%25AE%2BP188%2BBio%2B%2526%2BCell%2BCulture.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/Open_Innovation/outline/SessionsDetail.4691.253059.Unlocking%2Bthe%2BPotential%2Bof%2BBlood%2Band%2BCells%2B%25E2%2580%2594%2BEnabling%2BTomorrow%25E2%2580%2599s%2BCell%2B%2526%2BGene%2BTherapies.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/Open_Innovation/outline/SessionsDetail.4691.253060.Introducing%2Ban%2BHRMS%2Bsolution%2Bfor%2BCQA%2Banalysis%2Bof%2Bantibody%2Band%2Bconjugate%2Bplatforms..htmlhttps://www.bioplusinterphex.co.kr/en-us/program/Open_Innovation/outline/SessionsDetail.4691.253061.Model-driven%2BGenetic%2BDesign%2Band%2BBioprocess%2BOptimization%2Bacross%2BModalities.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/Open_Innovation/outline/SessionsDetail.4691.253062.TED-A9%253A%2BClinical%2BEvidence%2BDriving%2Bthe%2BNext-Generation%2BParkinson%25E2%2580%2599s%2BDisease%2BTherapy.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/Open_Innovation/outline/SessionsDetail.4691.253063.Extractables%2Band%2BLeachables%2Bstudy.htmlhttps://www.bioplusinterphex.co.kr/en-us/program/Open_Innovation/outline/SessionsDetail.4691.253064.Empowering%2BIVD%2BInnovation%2Bthrough%2BEmbase%2Band%2BEmbiology%253A%2BA%2BRegulatory%2Band%2BEvidence-Based%2BApproach..htmlhttps://www.bioplusinterphex.co.kr/en-us/program/Open_Innovation/outline/SessionsDetail.4691.253065.Antibody%2BTherapeutics%2B-%2BDecoding%2BAlphabet%253A%2Bas%2Bantibody%25E2%2580%2593drug%2Bconjugates%2B%2528ADCs%2529%2Band%2Bbispecific%2Bantibodies%2B%2528BsAbs%2529%2BSolutions%2Bbased%2Bon%2BCust.html